Emerging roles of Krüppel-like factor 4 in cancer and cancer stem cells

Bo Ding1, Ping Liu, Wen Liu

  • 1Department of Orthodontics, School of Stomatology, Shandong University, China

Insights

Cancer stem cells (CSCs) drive cancer recurrence and metastasis. Understanding how KLF4 regulates these cells is key to developing new cancer therapeutics targeting CSCs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Cancer stem cells (CSCs) are critical drivers of tumor recurrence, metastasis, and therapeutic resistance.
  • The precise molecular mechanisms governing CSC regulation remain largely unknown.
  • Kruppel-like factors (KLFs), particularly KLF4, are increasingly recognized for their roles in cancer and CSC biology.

Purpose of the Study:

  • To elucidate the transcriptional regulation of KLF4 within CSCs.
  • To explore the functional implications of KLF4 in CSCs for cancer therapy.
  • To deepen the understanding of KLF4's role in CSC-driven cancer progression.

Main Methods:

  • Literature review and synthesis of current research on KLF4 transcriptional regulation in CSCs.
  • Analysis of published data on KLF4 function in various cancer models.
  • Discussion of therapeutic strategies targeting CSCs based on KLF4 regulation.

Main Results:

  • KLF4 plays a significant role in maintaining CSC properties, including self-renewal and differentiation.
  • Transcriptional networks involving KLF4 are crucial for CSC survival and function.
  • Dysregulation of KLF4 contributes to cancer progression and therapeutic challenges.

Conclusions:

  • Targeting KLF4-mediated pathways in CSCs holds promise for novel cancer therapeutics.
  • A comprehensive understanding of KLF4's regulatory mechanisms is essential for effective cancer treatment strategies.
  • Further research into KLF4's role can lead to improved outcomes for patients with recurrent or metastatic cancers.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K